Skip to content

Bio Details

Seres' news, events and other information can be found throughout the pages below.

Matthew Henn, Ph.D.

Senior Vice President, Head of Drug Discovery & Bioinformatics
Matthew Henn has over 16 years of combined research experience in microbial ecology, genomics, and bioinformatics that span both environmental and infectious disease applications. Prior to joining Seres Therapeutics he was the Director of Viral Genomics and Assistant Director of the Genome Sequencing Center for Infectious Diseases at the Broad Institute of MIT and Harvard. Matt is an expert in the development, implementation, and application of various genomic technologies to the study of microbial populations and their metabolic function. He has over 60 peer-reviewed publications in microbiology and bioinformatics and he has led multiple large-scale international genomic projects. He has served as a consultant for the WHO’s Grand Challenges in Genomics for Public Health in Developing Countries, is a scientific advisor for NIH’s Viral Pathogen Bioinformatics Resource Center, and serves on the editorial board of Genome Medicine. Matt earned his Ph.D. in Ecosystem Sciences from the University of California at Berkeley, where he was a NASA Earth Systems Sciences Fellow, and trained as a NSF Postdoctoral Fellow in Microbiology at Duke University.

    Shareholder Tools